Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byAbbott Labs
Price$400M
Date9/2009

General Information

Websitevisiogen.com
CategoryMedical
Phone949-341-0700
Employees
Founded2001
DescriptionLens technology for cataracts

Offices

Visiogen
2 Goodyear, Suite B
Irvine, CA, 92618
USA

People

Funding

Tags

Visiogen

Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created the Synchrony dual optic accommodating intraocular lens (IOL) for use in the surgical treatment of these conditions.

The device is designed to provide patients with near, intermediate and distance vision in a seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery, the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States.

Recent Milestones

Videos

Screenshots

Sources

  1. Abbott To Pay $400 Million For Cataract-Treatment Firm Visiogen (smartmoney.com) [edit]
  2. Visiogen, Inc.: Series D $40M (onbiovc.com) [edit]
Edit This Page
Last Edited 1/14/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy